Cryogenic tech in IVF and fertility medicine has advanced considerably over the past decade, and the pace of development is accelerating. Several advances stand out as having the most direct operational relevance for fertility laboratories managing embryo, oocyte, and sperm storage programmes.
Vitrification protocols and carrier technology have been the most clinically significant development. The shift from slow-rate controlled freezing to ultra-rapid vitrification, which plunges biological material into liquid nitrogen at cooling rates that prevent ice crystal formation entirely, has transformed post-thaw survival rates. Accredited IVF laboratories using optimised vitrification protocols now routinely achieve post-thaw embryo survival rates of 80 to 95 per cent.
Vapour phase storage technology has addressed one of the persistent concerns with liquid phase cryogenic storage – the theoretical cross-contamination risk through shared liquid nitrogen. Modern vapour phase storage vessels maintain samples at temperatures between -140°C and -190°C in the cold nitrogen vapour above the liquid surface, eliminating liquid phase contact whilst maintaining temperature well below the -130°C biological preservation threshold.
IoT-enabled monitoring represents the most significant recent infrastructure development. The cryogenic storage market has evolved significantly, moving beyond simple vacuum-insulated vessels to include IoT-enabled monitoring, automated retrieval systems, and ultra-low nitrogen consumption technologies.
Ultra-low evaporation rate vessel designs incorporating advanced multilayer vacuum insulation are extending static holding times and reducing LN2 consumption, with direct implications for supply buffer calculation and operational cost.
Cryolab supplies advanced cryogenic storage technology for IVF laboratories and research institutions. View the full storage vessel range or speak with the Cryolab team about the right solution for your programme.
